Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Feb 20;3(2):225-231.
doi: 10.20517/cdr.2020.10. eCollection 2020.

"Pharmacogenetics of Cancer" - Cancer Drug Resistance special issue

Enrico Mini  1   2 , Stefania Nobili  1   2
Affiliations
Editorial

"Pharmacogenetics of Cancer" - Cancer Drug Resistance special issue

Enrico Mini et al. Cancer Drug Resist. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors declared that there are no conflicts of interest.

References

    1. Roden DM, McLeod HL, Relling MV, Williams MS, Mensah GA, et al. Pharmacogenomics. Lancet. 2019;394:521–32. doi: 10.1016/S0140-6736(19)31276-0. - DOI - PMC - PubMed
    1. Mini E, Nobili S. Pharmacogenetics: implementing personalized medicine. Clin Cases Miner Bone Metab. 2009;6:17–24. - PMC - PubMed
    1. Wake DT, Ilbawi N, Dunnenberger HM, Hulick PJ. Pharmacogenomics: prescribing precisely. Med Clin North Am. 2019;103:977–90. doi: 10.1016/j.mcna.2019.07.002. - DOI - PubMed
    1. Levitzki A, Klein S. My journey from tyrosine phosphorylation inhibitors to targeted immune therapy as strategies to combat cancer. Proc Natl Acad Sci U S A. 2019;116:11579–86. doi: 10.1073/pnas.1816012116. - DOI - PMC - PubMed
    1. Church D, Kerr R, Domingo E, Rosmarin D, Palles C, et al. ‘Toxgnostics’: an unmet need in cancer medicine. Nat Rev Cancer. 2014;14:440–5. doi: 10.1038/nrc3729. - DOI - PubMed

Publication types

LinkOut - more resources